Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Trial ID or NCT#
Status
Purpose
A lung condition called bronchopulmonary dysplasia (BPD) is a major cause of poor outcomes and death for premature infants. Infants with BPD are also at high risk for pulmonary hypertension (PH)-an important contributor to their condition. Previous research has suggested that a protein in the blood, endothelin-1 (ET-1), is associated with pulmonary disease. This study aims to investigate the incidence of PH and levels of ET-1 among premature babies with BPD. It will also potentially allow us to focus further research efforts and treatment towards these infants, some of our sickest patients at LPCH.
Official Title
Endothelin-1 (ET-1) Levels as Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia (BPD)
Eligibility Criteria
- * Premature Infants (\<30 weeks EGA)
- * Major congenital malformations (cardiac, respiratory, gastrointestinal)* congenital infection, and/or* known genetic syndromes (i.e. trisomy 21)
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Christine Johnson, MD
650 723-5711
View on ClinicalTrials.gov